CCIRC Okays New Effort To Rate Disease Committees, Modalities In Groups, Effective with Next Round
In Brief; NCAB Goes Along With NCI Staff In Funding EORTC Statistical Center Grant Out Of Priority Sequence
Organ Site Program Fate On Line, Gets Review Next Week
Hawking Hearings Turn Up Difference Between Management, Staff At FDA
Scientists Defend NCI, Criticize Post Series As Inaccurate
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
